TRINSEO PLC(NYSE:TSE) stock Fundamental Analysis

Fundamental Rating

Taking everything into account, TSE scores 2 out of 10 in our fundamental rating. TSE was compared to 85 industry peers in the Chemicals industry. TSE has a bad profitability rating. Also its financial health evaluation is rather negative. TSE has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

TSE had negative earnings in the past year.

In the past year TSE has reported a negative cash flow from operations.

In multiple years TSE reported negative net income over the last 5 years.

TSE had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -17.19%, TSE is not doing good in the industry: 87.95% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-17.19%
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

TSE has a worse Gross Margin (6.51%) than 87.95% of its industry peers.

In the last couple of years the Gross Margin of TSE has declined.

TSE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	6.51%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-19.47%

GM growth 5Y-3.22%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

TSE does not have a ROIC to compare to the WACC, probably because it is not profitable.

There is no outstanding debt for TSE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of 1.01, we must say that TSE is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 1.01, TSE is doing worse than 74.70% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	1.01

ROIC/WACCN/A

WACC6.52%

2.3 Liquidity

A Current Ratio of 1.38 indicates that TSE should not have too much problems paying its short term obligations.

The Current ratio of TSE (1.38) is worse than 74.70% of its industry peers.

TSE has a Quick Ratio of 1.38. This is a bad value and indicates that TSE is not financially healthy enough and could expect problems in meeting its short term obligations.

With a Quick ratio value of 0.84, TSE is not doing good in the industry: 75.90% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	1.38
Quick Ratio	0.84

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for TSE have decreased strongly by -10.65% in the last year.

TSE shows a decrease in Revenue. In the last year, the revenue decreased by -4.41%.

The Revenue has been growing slightly by 0.81% on average over the past years.

EPS 1Y (TTM)-10.65%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%10.7%

Revenue 1Y (TTM)-4.41%

Revenue growth 3Y-10.05%

Revenue growth 5Y0.81%

Sales Q2Q%-1.91%

3.2 Future

The Earnings Per Share is expected to grow by 20.67% on average over the next years. This is a very strong growth

The Revenue is expected to grow by 2.83% on average over the next years.

EPS Next Y35.98%

EPS Next 2Y26.25%

EPS Next 3Y20.67%

EPS Next 5YN/A

Revenue Next Year2.87%

Revenue Next 2Y2.83%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

TSE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TSE. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

TSE's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. TSE is more expensive than 62.65% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	14.3

4.3 Compensation for Growth

TSE's earnings are expected to grow with 20.67% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y26.25%

EPS Next 3Y20.67%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a yearly dividend of 0.70%, TSE is not a good candidate for dividend investing.

TSE's Dividend Yield is comparable with the industry average which is at 3.28.

Compared to an average S&P500 Dividend Yield of 2.27, TSE's dividend is way lower than the S&P500 average.

		Industry Rank	Sector Rank
Dividend Yield	0.7%

5.2 History

The dividend of TSE decreases each year by -20.01%.

TSE has paid a dividend for at least 10 years, which is a reliable track record.

Dividend Growth(5Y)-20.01%

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

The earnings of TSE are negative and hence is the payout ratio. TSE will probably not be able to sustain this dividend level.

DP-0.32%

EPS Next 2Y26.25%

EPS Next 3Y20.67%

More info and screens

Find the best dividend stocks

Show peers with best dividend

TRINSEO PLC

NYSE:TSE (2/24/2025, 3:19:37 PM)

5.48

-0.04 (-0.72%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)02-12 2025-02-12/amc

Earnings (Next)N/A N/A

Inst Owners71.81%

Inst Owner Change-97.87%

Ins Owners4.87%

Ins Owner Change-0.57%

Market Cap193.99M

Analysts50

Price Target5.61 (2.37%)

Short Float %3.91%

Short Ratio3.32

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0.7%

Yearly Dividend0.51

Dividend Growth(5Y)-20.01%

DP-0.32%

Div Incr Years0

Div Non Decr Years0

Ex-Date01-10 2025-01-10 (0.01)

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-12.26%

Min EPS beat(2)-15.41%

Max EPS beat(2)-9.11%

EPS beat(4)1

Avg EPS beat(4)-36.07%

Min EPS beat(4)-122.75%

Max EPS beat(4)2.99%

EPS beat(8)1

Avg EPS beat(8)-74.84%

EPS beat(12)2

Avg EPS beat(12)-54.05%

EPS beat(16)5

Avg EPS beat(16)-37.92%

Revenue beat(2)0

Avg Revenue beat(2)-3.48%

Min Revenue beat(2)-3.76%

Max Revenue beat(2)-3.2%

Revenue beat(4)1

Avg Revenue beat(4)-1.33%

Min Revenue beat(4)-3.76%

Max Revenue beat(4)4.44%

Revenue beat(8)1

Avg Revenue beat(8)-5.97%

Revenue beat(12)2

Avg Revenue beat(12)-4.67%

Revenue beat(16)4

Avg Revenue beat(16)-3.67%

PT rev (1m)3.77%

PT rev (3m)0%

EPS NQ rev (1m)-7.34%

EPS NQ rev (3m)-6.09%

EPS NY rev (1m)-38.71%

EPS NY rev (3m)-56.1%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-1.8%

Revenue NY rev (1m)0.65%

Revenue NY rev (3m)-2.04%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.05
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	14.3

EPS(TTM)-7.69

EYN/A

EPS(NY)-4.92

Fwd EYN/A

FCF(TTM)-4.08

FCFYN/A

OCF(TTM)-2.31

OCFYN/A

SpS99.69

BVpS-13.56

TBVpS-33.27

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-17.19%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	6.51%
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-19.47%

GM growth 5Y-3.22%

F-Score3

Asset Turnover1.22

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	12.87
Cap/Depr	29.24%
Cap/Sales	1.78%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.38
Quick Ratio	0.84
Altman-Z	1.01

F-Score3

WACC6.52%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-10.65%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%10.7%

EPS Next Y35.98%

EPS Next 2Y26.25%

EPS Next 3Y20.67%

EPS Next 5YN/A

Revenue 1Y (TTM)-4.41%

Revenue growth 3Y-10.05%

Revenue growth 5Y0.81%

Sales Q2Q%-1.91%

Revenue Next Year2.87%

Revenue Next 2Y2.83%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y73.06%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year860.04%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-333.06%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-149.49%

OCF growth 3YN/A

OCF growth 5YN/A

TRINSEO PLC (TSE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens